New Delhi metallo 1: Have carbapenems met their doom?

Clinical Infectious Diseases

Volumn 51, Issue 10, 2010, Pages 1222-

  Deshpande, Payal ^a   Shetty, Anjali ^a   Kapadia, Farhad ^a   Hedge, Ashit ^a   Soman, Rajeev ^a   Rodrigues, Camilla ^a  

^a P D HINDUJA NATIONAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CARBAPENEMASE; COLISTIN; NEW DELHI METALLO 1 ENZYME; TIGECYCLINE; UNCLASSIFIED DRUG;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; CITROBACTER; DRUG HYDROLYSIS; ENTEROBACTERIACEAE; ESCHERICHIA COLI; HUMAN; KLEBSIELLA; LETTER; MORGANELLA MORGANII; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS; RISK FACTOR;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; INDIA;

EID: 78349287030     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/656921     Document Type: Letter

References (3)

1. Gupta E, Mohanty S, Sood S, Dhawan B, Das BK, Kapil A. Emerging resistance to carbapenems in a tertiary care hospital in north India. Indian J Med Res 2006; 124:95-8. (Pubitemid 44304650)
2. Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 2007; 20: 440-58.
3. Deshpande P, Rodrigues C, Shetty A, Kapadia F, Hegde A, Soman R. New Delhi metallo-β lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised. J Assoc Physicians India 2010; 58:147-9.